Mursla Bio

Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of a non-invasive diagnostic platform designed for the early detection of cancer. Mursla Bio is based in Cambridge, United Kingdom and was founded in 2017. Its last reported valuation was $53.2 million in Apr 2025. It has raised $10.2 million.

Last reported valuation

$53.2M

Oct 2026

Priced at

—

Total raised

$10.2M

Last round

—

How much has Mursla Bio raised?

$10.2Macross 0 recorded rounds

Private Market View

More of Mursla Bio with a free Private Market View account

·Watch Mursla Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Mursla Bio investors

4 investors are on record for Mursla Bio, including London & Partners., TA Ventures, Government of UK and Grow London.

For fundraisers

Raising for a company like Mursla Bio?

4 investors have backed Mursla Bio.

See all 4 investors →

Frequently asked about Mursla Bio

How much has Mursla Bio raised?: Mursla Bio has raised $10.2M in total across 0 recorded funding rounds.